The two main types of corticostriatal neurons are those that project only intratelencephalically (IT-type), the intrastriatal terminals of which are 0.41 m in mean diameter, and those that send their main axon into pyramidal tract and have a collateral projection to striatum (PT-type), the intrastriatal terminals of which are 0.82 m in mean diameter. We used three approaches to examine whether the two striatal projection neuron types (striatonigral direct pathway vs striatopallidal indirect pathway) differ in their input from IT-type and PT-type neurons. First, we retrogradely labeled one striatal projection neuron type or the other with biotinylated dextran amine (BDA)-3000 molecular weight. We found that terminals making asymmetric axospinous contact with striatonigral neurons were 0.43 m in mean diameter, whereas those making asymmetric axospinous contact with striatopallidal neurons were 0.69 m. Second, we preferentially immunolabeled striatonigral neurons for D 1 dopamine receptors or striatopallidal neurons for D 2 dopamine receptors and found that axospinous terminals had a smaller mean size (0.45 m) on D 1 ϩ spines than on D 2 ϩ spines (0.61 m). Finally, we combined selective BDA labeling of IT-type or PT-type terminals with immunolabeling for D 1 or D 2 , and found that IT-type terminals were twice as common as PT-type on D 1 ϩ spines, whereas PT-type terminals were four times as common as IT-type on D 2 ϩ spines. These various results suggest that striatonigral neurons preferentially receive input from IT-type cortical neurons, whereas striatopallidal neurons receive greater input from PT-type cortical neurons. This differential cortical connectivity may further the roles of the direct and indirect pathways in promoting desired movements and suppressing unwanted movements, respectively.
Introduction
The cerebral cortex gives rise to a massive excitatory glutamatergic projection that provides the striatum with the information it needs for its role in motor control (Gerfen, 1992; Wilson, 1992) . This input primarily ends as terminals that make asymmetric synaptic contact with dendritic spines of striatal projection neurons, which make up ϳ95% of striatal neurons (Albin et al., 1989; Reiner and Anderson, 1990; Gerfen, 1992) . In each cortical region, two types of corticostriatal neuron can be distinguished (Wilson, 1987; Cowan and Wilson, 1994; Wright et al., 1999 Wright et al., , 2001 Reiner et al., 2003) . One type, which we refer to as the pyramidal tract (PT)-type, possesses 15-20 m perikarya found primarily in lower layer V, and their striatal projection arises as a collateral of the main axon as it traverses striatum in its course to the ipsilateral pyramidal tract (Wilson, 1987; Cowan and Wilson, 1994; Levesque et al., 1996a,b; Levesque and Parent, 1998; Reiner et al., 2003) . The second type projects to basal ganglia and cortex but not outside telencephalon. These neurons, which we refer to as the intratelencephalically projecting (IT)-type, possess 12-15 m perikarya found mainly in layer III and upper layer V (Landry et al., 1984; Wilson, 1987; Cowan and Wilson, 1994; Levesque et al., 1996a,b; Levesque and Parent, 1998; Wright et al., 1999 Wright et al., , 2001 Reiner et al., 2003) .
PT-type neurons give rise to focal clusters of fine processes and terminals (each cluster being ϳ250 m in diameter) scattered in striatum over a 1-2 mm region (Cowan and Wilson, 1994) . The PT input to striatum has attracted interest because it may provide striatum with a copy of the cortical motor signal transmitted to brainstem and spinal cord (Landry et al., 1984; Levesque et al., 1996a,b) . IT-type neurons project to ipsilateral striatum, as well as contralateral in many cases, and have a uniform intrastriatal arborization with sparse en passant terminals over a 1.5 mm expanse (Wilson, 1987; Cowan and Wilson, 1994; Wright et al., 1999 Wright et al., , 2001 . Previously (Reiner et al., 2003) , we noted that axospinous PT-type terminals in rat striatum are typically large (0.82 m in mean diameter) and irregular in shape, whereas axospinous IT-type terminals are characteristically small (average diameter of 0.41 m) and regular in shape (round or oval). Wright et al. (1999 Wright et al. ( , 2001 ) reported similar findings.
Consistent with the morphological differences between them, IT-type and PT-type corticostriatal neurons carry different signals, with PT-type neurons, but not IT-type neurons, showing movement-related activity (Turner and DeLong, 2000; Beloozerova et al., 2003) . To understand better how cortical input to the striatum participates in the role of the basal ganglia in movement control, it is important to know whether the two types of corticostriatal neurons project differentially to the two main types of striatal projection neurons, those of the direct pathway and those of the indirect pathway (Albin et al., 1989; DeLong, 1990) . To this end, we preferentially labeled one or the other of these two striatal projection neuron types by retrograde labeling or dopamine receptor immunolabeling and examined the size of the axospinous terminals on their dendrites. Additionally, we preferentially labeled one or the other striatal projection neuron type by dopamine receptor immunolabeling in tissue in which either PT-type or IT-type input had been selectively labeled with biotinylated dextran amine (BDA) (Reiner et al., 2003) . Our findings indicate that PT-type terminals preferentially contact indirect pathway striatal neurons, whereas IT-type terminals preferentially contact direct pathway neurons. These findings suggest that PT-type corticostriatal neurons may provide indirect pathway neurons with information about ongoing movements needed for their role in suppressing unwanted movements, whereas integration of ITtype input from diverse cortical areas may underlie the role of direct pathway neurons in promoting desired movements.
Materials and Methods
Animals and experimental plan. Results from 25 adult male Sprague Dawley rats (Harlan, Indianapolis, IN) are presented here. Efforts were made to minimize animal suffering and use as few animals as possible, and all animal use was performed in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals, Society for Neuroscience Guidelines, and University of Tennessee Health Science Center Guidelines.
In the first set of studies, we characterized the size of terminals making asymmetric axospinous contact with striatal neurons projecting to the globus pallidus (GP) [the homolog of the primate external segment of globus pallidus (GPe)], that is, indirect pathway striatal neurons (Albin et al., 1989; DeLong, 1990) , compared with those making asymmetric axospinous contact with striatal neurons projecting to the substantia nigra (SN) and/or the entopeduncular nucleus (EP) [the homolog of the primate internal segment of globus pallidus (GPi)], that is, direct pathway striatal neurons (Albin et al., 1989; DeLong, 1990) . In three rats, the retrograde tracer BDA3k [dextran, biotinylated, 3000 molecular weight (MW), anionic, lysine fixable; Molecular Probes, Eugene, OR] was injected bilaterally into GP, and in four rats BDA3k was injected bilaterally into the SN. The injection site in representative cases of each injection type is shown (see Fig. 1 ). Injection of retrograde tracer into GP predominantly labels striato-GP neurons (which are enkephalinergic), as well as some striatonigral and striato-EP neurons [which characteristically contain substance P (SP)] because of their slight collateralization within the GP (Kawaguchi et al., 1990; Reiner and Anderson, 1990; Wu et al., 2000; . Injections of retrograde tracer into substantia nigra labels direct pathway striatal neurons projecting to substantia nigra, which include neurons projecting to both EP and substantia nigra pars reticulata (SNr) and neurons projecting to SNr but not EP (Kawaguchi et al., 1990; Reiner and Anderson, 1990; Gerfen, 1992; Wu et al., 2000) . For simplicity, we will commonly refer to both types of direct pathway striatal neurons as striatonigral, because both project to nigra in rodents. Injections of retrograde tracer into the substantia nigra do not label striato-GP neurons, because these neurons do not send a collateral to nigra (Kawaguchi et al., 1990; Wu et al., 2000; . We analyzed by electron microscopy (EM) the size and shape of terminals making asymmetric axospinous synaptic contact on spine heads of the retrogradely labeled striato-GP and striatonigral neurons in the dorsolateral somatomotor sector of the striatum. The size of terminals was determined by measuring them at their widest diameter parallel to the postsynaptic density, and spines were identifiable by their size, continuity with dendrites, prominent postsynaptic density, and/or the presence of spine apparatus (Wilson et al., 1983) . We focused our attention on dorsolateral striatum so as to minimize inclusion of striosomal neurons, which project to pars compacta of the nigra (Gerfen, 1992) and are scarce in dorsolateral striatum (Gerfen, 1992; Desban et al., 1993) , among the striatonigral neurons analyzed. Thus, in the analyzed sample of retrogradely labeled neurons projecting to nigra, striato-SNr neurons are likely to have been the most abundant, because they are approximately twice as common as striato-EP neurons in rats (Kawaguchi et al., 1990; Wu et al., 2000) . For GP injections, by only analyzing labeled neurons in dorsolateral striatum, we were also able to avoid any neurons incidentally labeled by passage of the syringe through medial striatum in its course to GP.
In our second set of studies, we sought also to characterize the size of the terminals making axospinous contact with striato-GP neurons compared with those making axospinous contact with striatonigral neurons. In this set of studies, we relied on the finding that striato-GP neurons are enriched in D 2 receptors but poor in D 1 receptors, whereas striatonigral neurons are enriched in D 1 receptors but poor in D 2 receptors (Gerfen et al., 1990; Le Moine and Bloch, 1995) . We used D 1 immunolabeling as an alternative way of preferentially labeling striatonigral direct pathway neurons, therefore, and D 2 immunolabeling as an alternative means for preferentially labeling indirect pathway striato-GP neurons. Included among the neurons immunolabeled for D 1 are those projecting primarily to the nigra, as well as those projecting both to EP and nigra (Parent et al., 1989 (Parent et al., , 1995 Kawaguchi et al., 1990; Hersch et al., 1995; Wu et al., 2000) . We analyzed by EM the percentage of spines labeled for either D 1 or D 2 (or both) and determined the size and shape of those terminals making asymmetric axospinous synaptic contacts on immunolabeled spine heads. Terminals were again measured at their widest diameter parallel to the postsynaptic density. Note that although indirect pathway striato-GP neurons in rat characteristically contain enkephalin (ENK) and direct pathway striatonigral neurons characteristically contain SP, immunolabeling for these neuropeptides does not provide a reliable means for labeling the perikarya and dendrites of these neuron types, because they appear to rapidly ship the neuropeptides to their terminals in GP and substantia nigra, respectively, and retain little in their perikarya and dendrites .
Finally, to directly determine whether IT-type terminals preferentially contact either striato-GP or striatonigral neurons, nine rats received unilateral injections of BDA10k (dextran, biotinylated, 10,000 MW, anionic, lysine fixable; Molecular Probes) into motor cortex on the left side of the brain. In these cases, anterograde corticostriatal labeling in the right striatum would be limited to IT-type terminals, because PT-type corticostriatal neurons do not project to contralateral striatum, but IT-type neurons do (Cowan and Wilson, 1994; Reiner et al., 2003) . Before the surgery required for the injection of the BDA10k, the animals were deeply anesthetized with 0.1 ml/100 mg of a mixture of ketamine (87 mg/kg) and xylazine (13 mg/kg). A 1 l Hamilton microsyringe was used to inject 5% BDA10k in 0.1 M phosphate buffer (PB), pH 7.4, using stereotaxic methods as described previously (Reiner et al., 2000 (Reiner et al., , 2003 , using coordinates from the Paxinos and Watson (1998) stereotaxic atlas of the rat brain to target the injections. To directly determine whether PT-type terminals preferentially contact either indirect pathway striato-GP or direct pathway striatonigral neurons, in seven other rats, 0.15 l of 10% BDA3k (dextran, biotinylated, 3000 MW, anionic, lysine fixable; Molecular Probes) in 0.1 M sodium citrate-HCl, pH 3.0 (Reiner et al., 2000) , was injected bilaterally, using a 1 l Hamilton microsyringe, into the pyramidal tract at caudal pontine levels to produce selective labeling of the intrastriatal collaterals of these neurons (Reiner et al., 2003) , using stereotaxic coordinates from the atlas of Paxinos and Watson (1998) . Alternate sections from rats with successful labeling of IT-type or PT-type terminals in right striatum were then processed for D 1 or D 2 immunolabeling, and all were processed for ABC visualization of the terminal labeling. As in our second line of study, D 1 immunolabeling served as a way of preferentially detecting direct pathway striatonigral neurons and D 2 immunolabeling as a means for preferentially detecting indirect pathway striato-GP neurons. To analyze this material, we used EM to locate BDA-labeled terminals that made asymmetric synaptic contact with spine heads in the striatum. For each such terminal, we tabulated whether the spine head contacted was immunolabeled (for D 1 in D 1 -immunolabeled tissue or for D 2 in D 2 -immunolabeled tissue). This information was used to determine the percentage of IT-type and PTtype terminals synaptically contacting either D 1 or D 2 spines. We also counted all labeled and unlabeled spines not receiving a BDAϩ asymmetric synaptic input in these same fields of view. This information was used to determine the percentage of D 1 and D 2 spines in the fields examined that received an asymmetric synaptic contact from an IT-type or PT-type terminal. The size of the BDAϩ terminals was also measured, again at the widest diameter parallel to the postsynaptic density. Synaptic contacts in all studies were identified by the presence of synaptic vesicles in the terminal and a postsynaptic density in the target spine.
Tissue fixation and processing. After 7-10 d, the rats that had been injected with BDA for ultrastructural visualization of retrogradely BDA3k-labeled striatal projection neuron spines or BDA-labeled intrastriatal corticostriatal terminals were deeply anesthetized with 0.8 ml of 35% chloral hydrate in saline and then perfused transcardially as by Reiner et al. (2003) . The rats were first exsanguinated by perfusion with 30 -50 ml of 6% dextran in PB, followed by 400 ml of 3.5% paraformaldehyde-0.6% glutaraldehyde-15% saturated picric acid in PB, pH 7.4. The brain of each was then removed, postfixed overnight in the same fixative without glutaraldehyde, and then sectioned at 50 m on a vibratome. Rats without BDA injections that were to be used for studies of the size of axospinous terminals on D 1 -or D 2 -immunolabeled spines (n ϭ 4) were similarly transcardially perfused with fixative. Tissue with retrograde BDA3k labeling of striato-GP or striatonigral neurons was next processed for visualization of the BDA. Tissue intended solely for study of the size and shape of axospinous terminals on D 1 -immunolabeled or D 2 -immunolabeled spines, on the other hand, was processed immunocytochemically with anti-D 1 or anti-D 2 . Finally, tissue intended for simultaneous visualization of BDA labeling of corticostriatal terminals and immunolabeling of D 1 and D 2 dopamine receptors was processed first by the ABC procedure for BDA localization and then immunolabeled for D 1 or D 2 . These various approaches are described in more detail in the following sections.
Visualization of dextran amines. Single-label visualization of BDA with light microscopy (LM) was used to ascertain the accuracy of injection sites, the abundance of retrogradely labeled striatonigral and striato-GP neurons in cases in which BDA had been injected into striatal target areas, or the abundance of BDA-labeled IT-type or PT-type terminals in cases in which the BDA had been injected into cortex or pons. Additional sections through the striatum from each case were processed for EM viewing. All sections were first pretreated with 1% sodium borohydride in 0.1 M PB for 30 min followed by incubation in 0.3% H 2 O 2 solution in 0.1 M PB for 30 min. BDA was then visualized by using the ABC Elite kit (Vector Laboratories, Burlingame, CA) from which a 5 ml volume of the ABC solution was prepared in 0.01 M PBS by adding 50 l of avidin-DH and 50 l of biotinylated horseradish peroxidase. Sections were incubated in this solution for 1-2 hr at room temperature or overnight at 4°C (Reiner et al., 2000) . After PB rinses, the sections were immersed for 10 -15 min in 0.05% diaminobenzidine tetrahydrochloride (DAB) (Sigma, St. Louis, MO) in 0.1 M PB, pH 7.2, containing 0.04% nickelammonium sulfate. Hydrogen peroxide was then added to the solution to a final concentration of 0.01%, and the sections were incubated in this solution for an additional 15 min. The sections were subsequently washed six times in PB. Sections to be viewed by LM were mounted onto gelatin-coated slides, dried, and then dehydrated, cleared with Pro-par (Anatech, Battle Creek, MI) or xylene, and coverslipped with Permount (Fisher Scientific, Pittsburgh, PA). Tissue to be examined by EM was rinsed, dehydrated, and flat embedded in plastic, as described below.
Single immunolabeling for D 1 and D 2 dopamine receptors. Sections were first pretreated with 1% sodium borohydride in 0.1 M PB for 30 min followed by incubation in 0.3% H 2 O 2 solution in 0.1 M PB for 30 min. Alternate sections from each rat were incubated in rat anti-D 1 (product #D-187; Sigma) or rabbit anti-D 2 (catalog #AB5084P Chemicon, Temecula, CA). These antibodies are selective for the 97 amino acid C-terminal fragment of human D 1 and a 28 amino acid fragment within the third cytoplasmic loop (aa 284 -311) of human D 2 (common to short and long isoforms), respectively (Hersch et al., 1995; Wang and Pickel, 2002) . To carry out conventional single-label immunohistochemistry, sections were incubated for 72 hr at 4°C in primary antiserum diluted 1:500 (D 1 ) or 1:200 (D 2 ) (or for some additional sections with both simultaneously) with 0.1 M Tris buffer containing 4% normal goat serum-1.5% bovine serum albumin. Sections were then rinsed and incubated in donkey anti-rat IgG or anti-rabbit IgG diluted 1:80 in 0.1 M Tris buffer, pH 7.4 (or both in cases in which the tissue had been incubated in both anti-D 1 and anti-D 2 ), followed by incubation in the appropriate rat or rabbit PAP complex diluted 1:200 in 0.1 M Tris buffer, pH 7.4 (or both in cases in which the tissue had been incubated in both anti-D 1 and anti-D 2 ), with each incubation at room temperature for 1 hr. The sections were rinsed between secondary and PAP incubations in three 5 min washes of PB. Subsequent to the PAP incubation, the sections were rinsed with three to six 10 min washes in 0.1 M PB, and a peroxidase reaction using DAB was performed. After the PB rinses, the sections were immersed for 10 -15 min in 0.05% DAB (Sigma) in 0.1 M PB, pH 7.2. Hydrogen peroxide was then added to a final concentration of 0.01%, and the sections were incubated in this solution for an additional 15 min. The sections were subsequently washed six times in PB. Sections to be viewed by LM were mounted onto gelatin-coated slides, dried, and then dehydrated, cleared with Pro-par (Anatech) or xylene, and coverslipped with Permount (Fisher Scientific). Tissue to be examined by EM was rinsed, dehydrated, and flat embedded in plastic, as described below.
Combined BDA labeling of terminals and immunolabeling for D 1 and D 2 dopamine receptors. A two-color DAB procedure (Reiner et al., 2000 (Reiner et al., , 2003 was used to double label tissue for visualization of BDA-labeled corticostriatal terminals and immunolabeled dopamine receptors, for both LM and EM viewing. The sections were first pretreated with 1% sodium borohydride in 0.1 M PB for 30 min followed by incubation in 0.3% H 2 O 2 solution in 0.1 M PB for 30 min. BDA was then visualized by using the ABC Elite kit (Vector Laboratories), using a nickel-intensified DAB procedure as described above. These sections were subsequently washed six times in PB, and immunohistochemical labeling for D 1 or D 2 was performed using a brown DAB reaction to visualize the D 1 or D 2 immunolabeling, as described above. For each BDA-injected case used for simultaneously visualizing corticostriatal terminals and striatal dopamine receptors, some sections were prepared for LM viewing. These sections were mounted onto gelatin-coated glass slides, dried, dehydrated, cleared with Pro-par (Anatech) or xylene, and coverslipped withinjections into pons or cortex do not yield labeling of striatal neurons, because spiny neurons do not project to either site , use of the same chromogen did not yield BDAlabeled spines that might be confused with dopamine receptor-immunolabeled spines.
Preparation of tissue for EM. After BDA visualization as described above (in the case of BDA-labeled tissue) or immunolabeling for D 1 or D 2 as described above (in the case of tissue used for determination of terminal size on D 1 -and D 2 -labeled spines or tissue with concurrent dopamine receptor immunolabeling of spines and BDA labeling of corticostriatal terminals), the sections were rinsed in 0.1 M sodium cacodylate buffer, pH 7.2, postfixed for 1 hr in 2% osmium tetroxide (OsO 4 ) in 0.1 M sodium cacodylate buffer, dehydrated in a graded series of ethyl alcohols, impregnated with 1% uranyl acetate in 100% alcohol, and flat embedded in Spurr's resin (Electron Microscopy Sciences, Fort Washington, PA). For the flat embedding, the sections were mounted on microslides pretreated with liquid releasing factor (Electron Microscopy Sciences). The Spurr's resinembedded sections were examined light microscopically for the presence of BDA-labeled axons and terminals in striatum. Pieces of embedded tissue were then cut from the striatum and glued to carrier blocks, and ultrathin sections were cut from these specimens with a Reichert ultramicrotome. The sections were mounted on mesh grids, stained with 0.4% lead citrate and 4.0% uranyl acetate using an LKBWallac (Gaithersburg, MD) Ultrastainer, and finally viewed and photographed with a Jeol (Peabody, MA) 1200 electron microscope. One or more series from each case used for ultrastructural analysis were also routinely processed for LM visualization of BDA labeling. Analysis and quantification was performed using the photographs of the EM labeling. LM and EM images were scanned and imported into Adobe Photoshop (Adobe Systems, San Jose, CA) to prepare the illustrations presented here.
Results
Size of terminals making asymmetric synaptic contact with spines of retrogradely labeled striatonigral versus striato-GP neurons In three rats, numerous neurons were labeled in the ipsilateral striatum after accurate BDA3k injection into the substantia nigra on one side of the brain (Figs. 1 A, C,  2 A, B) . In one additional rat, numerous neurons were labeled on each side after accurate BDA3k injection into each nigra. Similarly, in one rat, many neurons were labeled in the ipsilateral striatum after accurate BDA3k injection in the GP, on one side of the brain, and in two additional rats, numerous neurons were labeled on each side after accurate BDA3k injection into each GP (Figs. 1 B, D, 3C,D) . Camera lucida drawings of retrogradely labeled striatonigral and striato-GP neurons indicated that the perikaryal size of the two neuron types and the dendritic labeling of the two neuron types was indistinguishable, typically including evident labeling of tertiary and quaternary branches (Fig. 3 B, D) . Electron microscopic analysis revealed labeling of dendritic spines of both neuron types as well (Fig. 4) . Statistical analysis (by t tests) indicated no significant difference in the number and length of primary or higher-order dendritic branches between the two types of neurons or in perikaryal size. Analysis at the EM level revealed that asymmetric axospinous synaptic terminals on BDA-labeled striatonigral neuron spines were characteristically small (average of 0.43 Ϯ 0.003 m in diameter for 309 such terminals) and regular in shape (see Table 2 , Fig. 4 A, B) . In contrast, asymmetric axospinous synaptic terminals on BDA3k-labeled striato-GP neuron spines were characteristically larger (average of 0.69 Ϯ 0.017 m in diameter for 342 such terminals) and more commonly irregular in shape (Table 1, Fig. 4C,D) . , D) , and sample ultrastructural views of retrogradely labeled dendrites and spines of striatonigral ( E) and striato-GP ( F) neurons. Images C and D show that the perikarya and dendrites of striatonigral ( C) and striato-GP ( D) neurons were labeled with BDA3k, whereas images E and F show that this labeling included that of spines. BDA3k-labeled dendrites (ϩd) and spines (ϩs) are evident in E and F, and the labeled spines in each receive asymmetric synaptic contact from an unlabeled terminal (Ϫt) containing the round vesicles characteristic of excitatory inputfrom cortex.
Additionally, the synaptic zone in many cases (as judged by the postsynaptic density) tended to be lengthy and discontinuous. Thus, retrogradely labeled striatonigral and striato-GP neurons commonly differed in the size and shape of the terminals making asymmetric synaptic contact with their spines, with the terminal size difference being highly significant (Table 1, Fig. 5) . Given that the dendrites of the two neuron types were labeled to a similar extent, it seems unlikely that the difference in terminal size and shape stemmed from a bias toward sampling different parts of the dendritic tree of the two neuron types.
Size of terminals making asymmetric synaptic contact with D 1 -versus D 2 -immunolabeled spines
Immunostaining for D 1 , D 2 , and D 1 plus D 2 was intense in striatum, with little labeling in cortex (Fig. 6 A-C) . Highmagnification LM viewing revealed the immunostaining to be localized to striatal neuronal perikarya and dendrites, primarily along the cell membrane inner surfaces (Fig. 6 D-F ) . EM additionally revealed labeling of spines (Figs. 6G-I (Gerfen et al., 1990; Gerfen, 1992; Le Moine and Bloch, 1995) . The mean size of terminals making asymmetric synaptic contact with D 1 -immunolabeled spines (0.45 Ϯ 0.02 m, based on 867 spines in four rats) was significantly smaller than the mean size of terminals making asymmetric synaptic contact with D 2 -immunolabeled spines (0.61 Ϯ 0.05 m, based on 519 spines in the same four rats) ( Table 1, Figs. 5, 7) .
Targetting of BDA-labeled IT-type and PT-type terminals to D 1 -versus D 2 -immunolabeled spines
Counts of labeled spines at the EM level in the fields used for the analysis of BDA-labeled terminals on dopamine receptor immunolabeled spines showed that the mean percentage (ϮSEM) of spines labeled for D 1 in the D 1 -immunolabeled tissue was 50.7 Ϯ 1.7% (based on 1023 spines), and for D 2 in the D 2 -immunolabeled tissue was 47.1 Ϯ 4.4% (based on 799 spines). Thus, the percentage of spines labeled for D 1 or D 2 in the doublelabeled material closely resembled that in the immunolabelingalone material, suggesting that combining BDA labeling and immunolabeling did not significantly alter the dopamine receptor immunolabeling of spines. Double labeling for IT-type corticostriatal terminals and the spines of direct pathway striatonigral neurons (via D 1 immunolabeling) or of indirect pathway striato-GP neurons (via D 2 immunolabeling) showed that of all axospinous asymmetric IT-type synaptic terminals labeled with BDA in tissue immunolabeled for D 1 , a mean 50.9% of the ITtype terminals (for six striata in six rats) contacted D 1 spines (Table 2, Fig. 8 ). In contrast, of all axospinous asymmetric ITtype synaptic terminals labeled with BDA in tissue immunolabeled for D 2 , only an average of 12.6% (for seven striata in six rats) contacted D 2 spines. Thus, IT-type terminals labeled with BDA contacted D 1 spines four times more commonly than they contacted D 2 spines (significantly different at the 0.002 level by t test). Double labeling for PT-type corticostriatal terminals and the spines of direct pathway striatonigral neurons (via D 1 immunolabeling) or of indirect pathway striato-GP neurons (via D 2 immunolabeling) showed a different trend; of all axospinous asymmetric PT-type synaptic terminals labeled with BDA in tissue immunolabeled for D 1 , only a mean of 21.3% of PT-type terminals (in five striata in five rats) contacted D 1 spines, whereas of all axospinous asymmetric PT-type synaptic terminals labeled with BDA in tissue immunolabeled for D 2 , a mean of 50.5% (in five striata in four rats) contacted D 2 spines (Table 2, Fig. 9 ). This difference for PT-type terminals was significantly at the 0.005 level by t test. Thus, IT-type terminals preferentially contact D 1 spines, whereas PT-type terminals preferentially contact D 2 spines. The data also show that IT-type terminals (Table 2) are significantly smaller (0.40 -0.43 m) than PT-type terminals (Table 2 ) on both D 1 -immunolabeled and D 2 -immunolabeled spines (0.68 -0.72 m), as would be expected from our previous findings on the mean size of IT-type and PT-type terminals on striatal spines (Reiner et al., 2003) .
The preference of IT-type terminals for D 1 spines and PT-type terminals for D 2 spines is also evident when the data are used to calculate the percentage of spines of a given type that were observed to receive asymmetric IT-type or PT-type synaptic input (Table 3) . For example, in the fields examined (i.e., all fields containing a labeled IT-type corticostriatal terminal making asymmetric synaptic contact with a spine head), a mean of 23.7% of D 1 ϩ spines (in six striata in six rats) received IT input, whereas significantly fewer D 2 ϩ spines (a mean of only 10.2% in five striata in five rats) received IT-type input. For PT-type terminals, a significant D 2 ϩ spine preference was evident. In the fields examined (i.e., all fields containing a labeled PT-type corticostriatal terminal making asymmetric synaptic contact with a spine head), a mean of 40.1% of D 2 ϩ spines received PT-type synaptic input (in five striata in four rats), whereas a mean of only 12.4% of D 1 ϩ spines (in seven striata in six rats) received PT input. The corticostriatal terminal difference for D 2 spines was significant at the p ϭ 0.0003 level, whereas the difference for D 1 spines was nearly significant ( p ϭ 0.06). Thus, regardless of how the results of this study combining anterograde labeling of terminal types with immunolabeling of spines for D 1 or D 2 are examined, the findings consistently indicate that IT-type terminals preferentially contact the spines of direct pathway striatonigral neurons (preferentially possessing D 1 ), and PT-type terminals preferentially target the spines of indirect pathway striato-GP neurons (preferentially possessing D 2 ).
Discussion
Our three lines of study in rats suggest that IT input preferentially ends on direct pathway striatonigral neurons, whereas PT input preferentially ends on indirect pathway striato-GP neurons. This conclusion is consistent with previous evidence that although all striatal neurons respond to glutamatergic cortical input, the input to indirect pathway striatal neurons somehow differs from that to direct pathway neurons (Uhl et al., 1988; Zemanick et al., 1991; Berretta et al., 1997; Parthasarathy and Graybiel 1997) .
Main conclusions and technical considerations Selective retrograde labeling of striatonigral and striato-GP neurons
In our first line of study, we found the mean size of terminals making axospinous asymmetric synaptic contact with spines of striatal neurons retrogradely labeled with BDA3k from the sub- stantia nigra (0.43 m) closely matched that previously reported by us for IT-type terminals (0.41 m) (Reiner et al., 2003) . The uniformly small size of asymmetric axospinous terminals on neurons retrogradely labeled from nigra suggests that both striato-SNr (the predominant type projecting to nigra) and striato-EP neurons preferentially receive IT-type input. Because asymmetric axospinous thalamostriatal terminals are commonly closer in size to ITtype than PT-type terminals (Sadikot et al., 1992; Lei et al., 2004) , our study suggests direct pathway neurons may receive thalamostriatal input as well. Sidibe and Smith (1996) , in fact, reported that thalamostriatal terminals in monkey preferentially contact striato-GPi direct pathway rather than striato-GPe indirect pathway neurons. Only one type of striatal neuron projects exclusively to GP, and these contain ENK (Parent et al., 1989 (Parent et al., , 1995 Kawaguchi et al., 1990; Reiner and Anderson, 1990; Wu et al., 2000) . Although striatal neurons that project to nigra or EP, which commonly contain SP, have slight collateralization to GP (Kawaguchi et al., 1990; Wu et al., 2000) , the sparseness of these collaterals makes it likely that true striato-GP neurons predominated among our striatal neurons retrogradely labeled from GP. This interpretation is consistent with our finding by single-cell reverse transcription (RT)-PCR that 70% of striatal neurons retrogradely labeled from GP in rat contain ENK but not SP . Interestingly, the mean size of axospinous synaptic terminals on striatal neurons labeled from GP (0.69 m) is as would be expected if 70% of labeled neurons were striato-GP neurons receiving 0.82 m PT-type terminals and 30% were striato-EP-SNr neurons receiving 0.41 m IT-type terminals [(0.82 m ϫ 70%) ϩ (0.41 m ϫ 30%) ϭ 0.69 m]. Thus, our studies of retrogradely labeled striatal projection neurons suggest that PT-type terminals end preferentially on striato-GP neurons, and IT-type preferentially on striato-EP-SNr neurons.
Selective detection of striatonigral neurons by D 1 immunolabeling and striato-GP neurons by D 2 immunolabeling
The localization of D 1 and D 2 receptors to striatal projection neurons has been controversial, with immunolabeling and in situ hybridization histochemistry (ISHH) favoring segregation of D 1 to direct pathway neurons and D 2 to indirect pathway neurons (Gerfen et al., 1990; Gerfen, 1992; Hersch et al., 1995; Le Moine and Bloch, 1995) , and physiological, single-cell RT- Figure 5 . Histograms comparing the size frequency distribution of asymmetric synaptic terminals on striatonigral spines to the size frequency distribution of asymmetric synaptic terminals on striato-GP spines, with spine types based on either retrogradely labeling with BDA3k ( A) or immunolabeling for D 1 or D 2 dopamine receptors (B). In both A and B, the frequency for each spine type is expressed as a percentage of the total number of asymmetric axospinous contacts counted for that spine type (309 BDA3kϩ striatonigral spines, 342 BDA3kϩ striato-GP spines, 867 D 1 ϩ striatonigral spines, and 519 D 2 ϩ striato-GP spines). Note that the size range is lower and peak frequency less for terminals on labeled striatonigral neuron spines than on striato-GP neuron spines by either the retrograde labeling or immunolabeling method of identifying such spines. As shown in Table 2 , the mean size of the asymmetric axospinous synaptic terminals on striatonigral neurons is also significantly less than on striato-GP neurons. (C, F, I ) dopamine receptors. TheimmunostainingforD 1 ,D 2 ,andD 1 plusD 2 wasintenseinstriatum,withlittleincortex,asrevealedbythelow-powerLMimages(A-C). High magnification LM viewing revealed the immunostaining to be localized to striatal neuron perikarya (arrows) and dendrites (ϩd) (D-F). EM viewing additionally revealed labeling of spines (ϩs) receiving asymmetric synaptic contacts from terminals containing the round vesicles characteristic of the excitatory input from the cerebral cortex (G-I). Ϫt, Unlabeled terminals.
PCR and some ISHH studies providing evidence for significant D 1 -D 2 colocalization (Lester et al., 1993; Surmeier et al., 1993 Surmeier et al., , 1996 Aizman et al., 2000) . Although functionally significant D 1 -D 2 colocalization may occur in some striatal projection neurons, our EM immunolabeling indicates that the D 1 -immunolabeled and D 2 -immunolabeled spines in our sample primarily belonged to different striatal projection neuron populations, with under 10% of D 1 spines possessing D 2 and under 10% of D 2 spines possessing D 1 . In this light, our findings that the mean size of terminals making asymmetric synaptic contact with D 1 spines (0.45 m) was similar to that of IT-type terminals (0.41 Tables 2 and 3 , however, the IT-type terminals far more commonly contact D 1 than D 2 spines. ϩd, Labeled dendrites; Ϫt, unlabeled terminals; ϩt, labeled terminals. m), whereas the mean size of terminals making asymmetric synaptic contact with D 2 spines (0.61 m) was more similar to that of PT-type terminals (0.82 m) suggests, at the very least, that striato-EP-SNr neurons receive predominantly IT-type terminals, and striato-GP neurons receive many more PT-type terminals than do striato-EP-SNr neurons. The disparity between mean terminal size on D 2 ϩ spines and PT-type terminal size may not be as great as appears, because the mean size of PT-type terminals was less (0.70 m) in the current study combining spine immunolabeling with BDA terminal labeling than in our previous study of PT labeling alone (0.82 m) (Reiner et al., 2003) . Using the measured mean size of PT-type terminals in the current D 1 -and D 2 -immunolabeled tissue, it can be algebraically deduced from the size of the terminals on D 1 -immunolabeled spines that only 12.5% of the D 1 spines immunolabeled in our second line of study received PT-type input. This slight PT input to D 1 spines may reflect the existence of PT-recipient D 1 ϩ striato-GP neurons (possibly also possessing D 2 ), which would be consistent with reports that 10 -20% of striatal enkephalinergic neurons possess D 1 (Surmeier et al., 1996; Waszczak et al., 1998) . The minor PT input to D 1 spines could also mean that some D 1 ϩ striatonigral neurons possess PT-recipient spines, which is consistent with our findings from our third line of study combining D 1 spine immunolabeling with BDA-labeling of PT-type terminals.
Similarly, we algebraically deduced that only 32% of our D 2 -immunolabeled spines received terminals in the size range of IT-type or thalamic. This minor IT or thalamic input to D 2 spines may stem from spines belonging to D 2 ϩ striatonigral-EP neurons (possibly also possessing D 1 ), which would be consistent with reports that ϳ20% of striatonigral neurons possess D 2 (Gerfen et al., 1990; Surmeier et al., 1993) . It is also possible that the minority axospinous input to D 2 spines from small terminals reflects D 2 ϩ striato-GP neurons receiving IT input, which is consistent with our finding combining D 2 immunolabeling with BDA-labeling of IT-type terminals that at least 10.2% of D 2 spines receive IT-type input. The predominance of PT-type terminals relative to IT-type on D 2 ϩ spines revealed in our third line of study (Table 3) , however, suggests that many of the small terminals on D 2 ϩ spines may arise from thalamus. In any event, our findings on the size of terminals on D 2 -immunolabeled spines in our second line of study indicate that PT-type terminals predominate on striato-GP neurons.
Selective BDA labeling of IT-type and PT-type terminals
Because not all IT-type neurons of motor cortex project to contralateral striatum (Wilson, 1987; Cowan and Wilson, 1994; Reiner et al., 2003) , the synaptic targets of the contralateral ITtype terminals revealed in our third line of study may not be representative of all IT-type terminals. Two considerations argue against this possibility. First, although contralateral cortical projections differ from ipsilateral in their topographic organization and targeting of dendrites (Flaherty and Graybiel, 1993; Hersch et al., 1995) , there is no evidence they differ in size, physiology, or the cell type targeted (Wilson, 1987; Cowan and Wilson, 1994; Wright et al., 1999 Wright et al., , 2001 . Second, the conclusion from our study of contralateral BDA10k-labeled IT-type terminals that IT-type terminals prefer striatonigral (i.e., D 1 ϩ) spines is consistent with Figure 9 . EM images showing double labeling for BDA3k-labeled PT-type corticostriatal terminals and D 1 -immunolabeled (striatonigral) spines (ϩs) in rat striatum (A, C, E) and for BDA3k-labeled PT-type corticostriatal terminals and D 2 -immunolabeled (striato-GP) spines (B, D, F ). These images show that PT-type terminals make asymmetric synaptic contact with both D 1 -immunolabeled spines, as well as D 2 -immunolabeled spines. As shown in Tables 2 and 3 , however, the PT-type terminals far more commonly contact D 2 than D 1 spines.ϩt, Labeled terminals; Ϫt, unlabeled terminals; ϩd, labeled dendrites. our studies of terminal size on retrogradely labeled or D 1 -immunolabeled striatonigral spines. To selectively label PT-type terminals, we relied on the ability of BDA3k to label the intrastriatal collaterals of retrogradely labeled PT-type neurons (Reiner et al., 2000) and on the fact that IT-type neurons do not project extratelencephalically (Wilson, 1987; Cowan and Wilson, 1994) . This approach, however, does not allow us to be sure of the cortical region giving rise to any particular BDA3k-labeled PT-type terminal. Although we overcame this limitation to some extent by examining only dorsolateral striatum, which receives its major input from somatomotor-somatosensory cortex (Alloway et al., 1998; Hoffer and Alloway, 2001 ), we do not know whether PTtype neurons of somatosensory and motor cortex equally prefer striato-GP neurons.
Combining BDA labeling of terminals with immunolabeling of spines
The double-labeling approach of our third line of study showed that IT-type terminals commonly contact D 1 spines, whereas PTtype terminals commonly contact D 2 spines. We also found that a higher percentage of D 1 spines received IT terminals than received PT, whereas a higher percentage of D 2 spines received PT than IT. We presume that not all D 1 -immunolabeled or D 2 -immunolabeled spines received BDA-labeled terminals because not all corticostriatal terminals of a given type were BDA-labeled (notably IT-type terminals of ipsilateral origin were unlabeled), and some spines may have received thalamic input. One potential problem is that combining BDA labeling and immunolabeling could have decreased the frequency of D 1 -and D 2 -immunolabeled spines from that in our study involving dopamine receptor immunolabeling alone, so as to lead to underrepresentation of one type of spine or the other. Our counts of D 1 -or D 2 -immunolabeled spines in the double-labeled tissue revealed, however, that this was not the case. Finally, Hersch et al. (1995) reported findings similar to ours for the percentage of contralateral BDA-labeled terminals (IT-type) arising from primary motor cortex (M1) that synapse on D 1 -immunolabeled spines, 47% in their study compared with 50.9% in ours. They, however, reported a much higher percentage of contralateral BDA-labeled terminals from M1 to synapse on D 2 -immunolabeled spines than we did, 52% versus 12.6%. The basis of this disparity is uncertain, but may lie in the different anti-D 2 used, which could have differed in their specificities in some manner not reflected in the frequency of spine labeling. Nonetheless, our conclusions about the target preference of IT-type and PT-type terminals from our double-label study are consistent with those of our first two lines of study.
Functional implications
Striato-EP-SNr neurons are thought to promote desired movement, and striato-GP neurons to inhibit unwanted movement (Albin et al., 1989; DeLong, 1990) . Because PT-type input conveys a copy of the cortical motor signal (Miller, 1975; Oka and Jinnai, 1978; Landry et al., 1984; Mink, 1996) , it may enable striato-GP neurons to inhibit behaviors that might otherwise conflict with movements initiated by the motor signal to brainstem. This may explain why striatal neurons that fire in association with movement commonly do not fire before movement onset (Jaeger et al., 1995; Mink, 1996) . The larger size of PT-type terminals than IT-type and their tendency to be apposed to perforated postsynaptic densities may augment their synaptic efficacy (Geinisman, 1993; Sulzer and Pothos, 2000) . This might explain why striato-GP neurons appear more responsive to cortical input than striato-EP-SNr neurons (Uhl et al., 1988; Parthasarathy and Graybiel 1997 ) and more avidly take up and anterogradely transmit the cortically injected H129 strain of herpes simplex virus (Zemanick et al., 1991) . Perforated postsynaptic densities also indicate sites of synaptic potentiation (Geinisman, 1993; Geinisman et al., 1996; Sulzer and Pothos, 2000; Topni et al., 2001) . Because the basal ganglia is involved in motor learning (Calabresi et al., 1992; Marsden and Obeso, 1994; Gabrieli, 1995; Graybiel and Kimura, 1995) , the PT input to striato-GP neurons may participate in learned suppression of conflicting movements. Finally, the small size of the IT-type terminals and the diffuse nature of the IT projection to striatum may require synchrony of firing from diverse cortical areas for IT input to activate striato-EP-SNr neurons (Wilson, 1992) . This is consistent with the presumed role of direct pathway neurons in promoting movement based on integration of diverse cortical input and with evidence for convergent projections from related cortical areas to individual striatal domains (Flaherty and Graybiel, 1991; Brown et al., 1998; Hoffer and Alloway, 2001 ).
